List of insiders holdings for AN2 Therapeutics Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| Leonard Braden Michael 10% Owner | 2024-08-14 20:24:00 | 0 5,749,432 | 5,749,432 | Form 4 |
| Adjuvant Global Health Technology Fund L.P. Adjuvant Global Health Technology Fund DE L.P. Adjuvant Capital GP L.P. Adjuvant Capital Management LLC 10% Owner | 2024-02-09 07:06:25 | 2,473,500 0 | 2,473,500 | Form 13G |
| RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. 10% Owner | 2024-08-13 17:40:01 | 1,999,997 0 | 1,999,997 | Form 13G |
| Easom Eric Chief Executive Officer | 2024-11-18 20:51:42 | 101,130 1,259,882 | 1,361,012 | Form 4 |
| Zakrzewski Joseph S Director | 2024-11-20 16:11:58 | 123,199 405,880 | 529,079 | Form 4 |
| Eizen Joshua M See Remarks | 2024-11-05 16:51:24 | 189,335 0 | 189,335 | Form 4 |
| Wong Stephanie Director | 2024-06-21 17:50:49 | 64,503 0 | 64,503 | Form 4 |
| Martin Patricia A. Director | 2024-06-21 17:56:38 | 64,503 0 | 64,503 | Form 4 |
| Spigelman Melvin K Director | 2024-06-21 17:58:43 | 64,503 0 | 64,503 | Form 4 |
| Aziz Kabeer Director | 2024-06-21 18:16:07 | 64,503 0 | 64,503 | Form 4 |
| FitzPatrick Margaret M Director | 2024-06-21 18:18:17 | 64,503 0 | 64,503 | Form 4 |
| Marks Gilbert Lynn Director | 2024-06-21 18:20:27 | 64,503 0 | 64,503 | Form 4 |
| Readnour Robin Shane Director | 2024-06-21 18:22:17 | 64,503 0 | 64,503 | Form 4 |
| Prior Stephen David Chief Strategy Officer | 2024-11-05 16:57:11 | 55,592 0 | 55,592 | Form 4 |
| Eckburg Paul Chief Medical Officer | 2024-03-29 16:19:03 | 51,416 0 | 51,416 | Form 4/A |
| Krause Kevin Michael Chief Strategy Officer | 2024-03-29 16:17:22 | 31,914 0 | 31,914 | Form 4/A |
| Day Lucy Chief Financial Officer | 2024-03-29 16:18:45 | 30,627 0 | 30,627 | Form 4/A |
| Chanda Sanjay Chief Development Officer | 2024-03-29 16:16:55 | 28,235 0 | 28,235 | Form 4/A |
| Nazak Michael Adrian Chief Accounting Officer | 2023-02-17 19:23:22 | 16,600 0 | 16,600 | Form 4 |